InfuSystem Holdings, Inc.
AMEX:INFUMedical - Instruments & Supplies
+$0.35 today
- Market cap
- $293.89M
- Beta
- 1.42
- P/E (TTM)
- 23.2
- EPS (TTM)
- $0.39
Volume 0.16M
Average 0.16M
INFU Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
InfuSystem Holdings, Inc.AMEX: INFU
Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Investing cash flow declines year over year
Q1 FY2026 investing cash flow of $1.26M (cash outflow) fell 52.6% year over year, ahead of the -65.2% change in trailing-twelve-month investing cash flow. Sequentially, it fell 42.5% from the prior quarter. Over 3 fiscal years it compounded at -16.1% a year.
Context
- Investing cash flow amounted to 4.7% of revenue in FY2025, down 5.1 pp from a year earlier.
- Investing cash flow grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -52.6% holds above the trailing-twelve-month pace of -65.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (6.79M) USD
- Year-over-year change
- +48.7%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (6.79M) | +48.7% |
| FY2024 | 2024-12-31 | (13.24M) | -96.6% |
| FY2023 | 2023-12-31 | (6.73M) | +41.3% |
| FY2022 | 2022-12-31 | (11.48M) | +46.2% |
| FY2021 | 2021-12-31 | (21.32M) | — |
Investing Cash Flow vs competitors
How INFU compares with its peers on the latest reported figures
- INFU's LTM Mar 2026 investing cash flow of $5.39M is the 2nd largest of the 3 companies compared; the peer median is $40.18M.
- Its year-over-year change of -65.2% is the 2nd highest of 3, against a peer median of -114.9%.
- Investing cash flow amounts to 3.8% of revenue for INFU, versus a peer median of 2.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $79.77M | -165.8% | — | 3.7% | |
| LTM Mar 2026 | $5.39M | -65.2% | -16.1% | 3.8% | |
| LTM Mar 2026 | $592.84K | -64.0% | -30.3% | 1.4% | |
| Peer median (excluding INFU) | $40.18M | -114.9% | -30.3% | 2.5% | |
Competitors are the stored peer set for INFU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.42M | 18K | 872K | 2.35M | 6.63M |
| Depreciation & Amortization | 14.63M | 13.36M | 12.51M | 12.5M | 13.29M |
| Deferred Income Tax | (153K) | 19K | 633K | 1.92M | 2.73M |
| Stock-Based Compensation | 6.4M | 3.83M | 4.07M | 4.46M | 4.36M |
| Change in Working Capital | (2.69M) | 385K | (5.56M) | 652K | (94K) |
| Accounts Receivables | 829K | (1.15M) | (2.36M) | (701K) | 263K |
| Inventory | (864K) | (882K) | (1.58M) | (126K) | 1.14M |
| Accounts Payables | (2.36M) | 2.94M | 2.42M | (676K) | (708K) |
| Other Working Capital | (294K) | (522K) | (4.03M) | 2.16M | (789K) |
| Other Non-Cash Items | (1.29M) | (90K) | (1.3M) | (1.42M) | (2.51M) |
| Operating Cash Flow | 18.32M | 17.52M | 11.22M | 20.46M | 24.41M |
| Capital Expenditures | (16.66M) | (15.08M) | (11.12M) | (17.83M) | (560K) |
| Acquisitions (Net) | (7.98M) | 3.6M | 4.38M | 4.59M | (1.41M) |
| Purchases of Investments | 0 | (14.09M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 10.5M | 0 | 0 | 0 |
| Other Investing Activities | 3.32M | 3.6M | 4.38M | (12.15M) | (4.82M) |
| Investing Cash Flow | (21.32M) | (11.48M) | (6.73M) | (13.24M) | (6.79M) |
| Debt Repayment | (5.47M) | (13K) | (3.95M) | (5.32M) | (4.32M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 335K |
| Common Stock Repurchased | (1.73M) | (6.65M) | (1.31M) | (2M) | (10.97M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 738K | 605K | 835K | 387K | 0 |
| Financing Cash Flow | (6.46M) | (6.06M) | (4.42M) | (6.92M) | (14.96M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (9.46M) | (21K) | 66K | 296K | 2.66M |
| Free Cash Flow | 1.66M | 2.44M | 106K | 2.63M | 23.85M |
InfuSystem Holdings, Inc.
AMEX:INFU
Intrinsic Alpha fair value
Locked
Current Price
$14.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.